Who are the bad boys? HFTP (Promethean?), Brown Simpson (Ltd and LP?).
Do not bother to use altavista to search for
"Brown Simpson" unless, that is, you wan to revisit gloves that
don't fit, DNA tests, and the whole sorry like.
Celeyroot seems to know something about these people. FWIW celery
was all over the TCLN toxic a while ago and he/she has been proven
right. I would not dismiss his/her concerns, even though they are
expressed, say, "tersely." -g-
From the recent proxy:
NUMBER OF SHARES
NAME AND ADDRESS BENEFICIALLY OWNED PERCENTAGE
- ----------------------------------------- ------------------ ----------
Hoechst Marion Roussel, Inc. 3,004,436 (1) 10.5%
Route 202-206Bridgewater, NJ 08807-0800
BB Biotech A.G. 2,293,000 (2) 8.0
c/o Bellevue Asset Management A.G.Grunstrasse 12 CH-6343Rothreuz, Switzerland
HFTP Investment LLC 2,194,185 (3) 7.7
c/o Promethean Investment Group, L.L.C.40 West 57th Street, Suite 1520
New York, NY 10019
Brown Simpson Strategic Growth Fund, Ltd. 950,813 (4) 3.3
152 West 57th Street, 40th FloorNew York, NY 10019
Brown Simpson Strategic Growth Fund, L.P. 511,976 (5) 1.8
...
* Indicates less than one percent
(1) Includes 3,004,436 shares of Series B Preferred Stock convertible into
3,004,436 shares of Common Stock sold to Hoechst Marion Roussel, Inc. in
connection with the joint venture agreement for establishing and operating
the Hoechst-ARIAD Genomics Center, LLC and represents 100% of the Series B
Preferred Stock.
(2) Such shares are held of record by Biotech Target S.A., a wholly owned
subsidiary of BB Biotech A.G. This information is based solely on review
of Schedules 13D and 13G, each of which was filed with the Commission on
May 28, 1998.
(3) Includes 3,000 shares of Series C Preferred Stock convertible into
2,194,185 shares of Common Stock and represents 60% of the Series C
Preferred Stock. Promethean Investment Group, LLC, a New York limited
liability company ("Promethean"), serves as investment advisor to HFTP
Investment, L.L.C. ("HFTP") and may be deemed to share beneficial
ownership of the shares beneficially owned by HFTP by reason of shared
power to vote and to dispose of the shares beneficially owned by HFTP.
Promethean disclaims beneficial ownership of the shares beneficially owned
by HFTP. Mr. James F. O'Brien, Jr. indirectly controls Promethean. Mr.
O'Brien disclaims beneficial ownership of the shares beneficially owned by
Promethean and HFTP.
(4) Includes 1,300 shares of Series C Preferred Stock convertible into 950,813
shares of Common Stock and represents 26% of the Series C Preferred Stock.
Brown Simpson Asset Management, L.L.C. serves as the investment manager to
Brown Simpson Strategic Growth Fund, Ltd. pursuant to an investment
management contract. The members of Brown Simpson Asset Management, L.L.C.
are Mitchell Kaye, Evan Levine, James Simpson and Matthew Brown. Such
persons may be deemed to have beneficial ownership of the shares owned by
Brown Simpson Strategic Growth Fund Ltd.
(5) Includes 700 shares of Series C Preferred Stock convertible into 511,976
shares of Common Stock and represents 14% of the Series C Preferred Stock.
The general partner of Brown Simpson Strategic Growth Fund, L.P. is Brown
Simpson Capital, L.L.C., the members of which are Mitchell Kaye, Evan
Levine, James Simpson and Matthew Brown. Such members may be deemed to
have beneficial ownership of the shares owned by Brown Simpson Strategic
Growth Fund, L.P. |
